EU Clinical Trials Regulations: The Impact of (CTR) No: 536/2014

In this audio recording, our panel of industry experts walk you through a PCI Clinical Services watercooler chat discussing all the changes, benefits and potential disadvantages that the new EU Clinical Trial Regulations No 536/2014 will bring when it is finally made effective, sometime in the summer of 2022

The team will also compare and contrast how the CTR will differ from the current EU Clinical Trials Directive 2001/20/EC which has been the principal legal directive in place since 2004 governing how clinical trials are conducted in the EU.

Impact of the EU Clinical Trials Regulation (CTR) No 536/2014 (WCC_Clinical_052121.mp3)

Our dedicated team of specialists will be happy to discuss any of your Clinical Trials Regulation questions or concerns. Contact us on +1 215-613-3600 (US) or +44 1495 711 222 (UK/EU) or email talkfuture@pci.com

Awards

We take pride in celebrating the accomplishments and accolades that distinguish PCI Pharma Services, our employees, and our services. These achievements are a testament to our commitment to excellence, innovation, and the unwavering dedication of our teams